Recombinant Saccharomyces cerevisiae Mediator of RNA polymerase II transcription subunit 19 (ROX3)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specific delivery times. Proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us.
Synonyms
ROX3; MED19; NUT3; SSN7; YBL093C; YBL0837Mediator of RNA polymerase II transcription subunit 19; Hypoxic gene repressor protein 3; Mediator complex subunit 19; Negative regulator of URS2 protein 3; SNF1 suppressor protein 7
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-220
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Target Names
ROX3
Target Protein Sequence
MASRVDETTV PSYYYYVDPE TTYTYQQPNP LQDLISVYGL DDISRQVART NLDGTKAVKL RKSYKNQIAD LSGKFSTIPT RENGKGGQIA HILFQNNPDM MIQPPQQGQN MSEQQWREQL RNRDIALFQP PNFDWDLCSS VLSQFERSYP SEFANQNQGG AQAPFDIDDL AFDLDGTGKS QSGSNSGNNS KKRKNKSSGS SMATPTHSDS HEDMKRRRLE
Uniprot No.

Target Background

Function
Mediator is a coactivator complex essential for RNA polymerase II transcription. It connects gene-specific regulators to the basal transcription machinery. Mediator is recruited to promoters, facilitating preinitiation complex assembly with RNA polymerase II. It unfolds, partially surrounding RNA polymerase II, interacting with its unphosphorylated C-terminal domain. Mediator dissociates and remains at the promoter during elongation.
Database Links

KEGG: sce:YBL093C

STRING: 4932.YBL093C

Protein Families
Mediator complex subunit 19 family
Subcellular Location
Nucleus.

Q&A

What is the functional role of ROX3/Med19 in Saccharomyces cerevisiae?

ROX3, also known as Med19, is a critical subunit of the Mediator complex in Saccharomyces cerevisiae. The Mediator is a 25-subunit complex that serves as a bridge between DNA-binding transcription factors and RNA polymerase II, facilitating both transcriptional activation and repression . Specifically, ROX3 plays a crucial role in maintaining structural integrity between the Middle module and the rest of the Mediator complex (Head and Tail modules).

Methodologically, ROX3 function has been characterized through deletion studies where researchers create Δmed19(rox3) strains and analyze the resulting phenotypes and Mediator complex structure alterations. These studies have demonstrated that both the intact and Head-Tail Δmed19(rox3) Mediator complexes have defects in:

  • Enhanced basal transcription

  • TFIIH phosphorylation of the RNA Polymerase II CTD

  • Binding of RNA Polymerase I

What experimental techniques are commonly used to study ROX3?

Several methodological approaches are employed in ROX3 research:

  • Genetic Manipulation

    • Generation of Δmed19(rox3) strains

    • Introduction of point mutations in ROX3

    • Complementation studies with wild-type or mutant ROX3

  • Biochemical Characterization

    • Mediator complex purification under varying conditions (mild vs. stringent)

    • Assessment of complex composition via mass spectrometry or western blotting

    • In vitro transcription assays to assess functional consequences

  • Functional Analysis

    • Measurement of basal and activated transcription in wild-type vs. mutant strains

    • Analysis of CTD phosphorylation by TFIIH

    • Assessment of RNA Pol I binding capacity

  • Structural Studies

    • Analysis of intermodule interactions within the Mediator complex

    • Characterization of Mediator architecture in presence/absence of ROX3

How does ROX3 deletion affect Mediator architecture and intermodule dynamics?

ROX3 deletion fundamentally alters the architectural stability of the Mediator complex in a condition-dependent manner. Research has revealed:

Purification ConditionsEffect on Mediator Complex in Δmed19(rox3) Strains
Mild conditionsComplex missing only ROX3/Med19 subunit
Stringent conditionsComplete dissociation of Middle module; stable Head-Tail association maintained

This differential behavior under varying conditions reveals that ROX3 functions both as:

  • A direct structural component providing primary stability

  • A reinforcing element that strengthens other intermodule interactions

The finding that Head and Tail modules remain stably associated even after Middle module dissociation challenges earlier models of Mediator structure that suggested independent association of these modules . This suggests a more complex network of interactions than previously understood.

Methodologically, these insights have been obtained through careful biochemical characterization of Mediator complexes purified from Δmed19(rox3) strains under different salt and detergent conditions, followed by comprehensive protein composition analysis.

What is the role of ROX3 in RNA Polymerase II CTD phosphorylation?

ROX3 plays a significant role in facilitating RNA Polymerase II C-terminal domain (CTD) phosphorylation. The CTD consists of multiple repeats of the heptapeptide sequence YSPTSPS, and its phosphorylation state coordinates different phases of the transcription cycle.

Experimental data demonstrates that Mediator complexes from Δmed19(rox3) strains show significant defects in enhanced TFIIH phosphorylation of the CTD . This implicates ROX3 in either:

  • Direct facilitation of TFIIH kinase activity

  • Proper positioning of the CTD for TFIIH access

  • Recruitment or stabilization of TFIIH at the transcription initiation complex

Methodologically, this role has been investigated through:

  • In vitro kinase assays with purified components

  • Western blotting with phosphorylation-specific CTD antibodies

  • Functional transcription assays correlating CTD phosphorylation with transcriptional output

The impaired CTD phosphorylation in Δmed19(rox3) strains provides a mechanistic explanation for the observed transcriptional defects, as proper CTD phosphorylation is essential for the transition from initiation to elongation and for recruitment of RNA processing factors.

How do the structural roles of ROX3 relate to transcriptional regulation mechanisms?

ROX3's dual function as both a structural component and transcriptional regulator raises important mechanistic questions. Research suggests the following relationship model:

  • Primary Structural Role: ROX3 maintains Mediator integrity by anchoring the Middle module to the Head and Tail modules .

  • Consequent Functional Effects: This structural integrity enables:

    • Proper presentation of interaction surfaces for transcription factors

    • Correct positioning of RNA Pol II for transcription initiation

    • Facilitation of TFIIH-mediated CTD phosphorylation

    • Stabilization of interactions with RNA Pol I

  • Signal Integration: The position of ROX3 potentially allows it to transmit conformational changes between Mediator modules in response to activator binding.

What methodological challenges exist in investigating ROX3 function?

Researchers face several significant challenges when studying ROX3:

  • Isolating Direct vs. Indirect Effects

    • Challenge: Distinguishing primary consequences of ROX3 deletion from secondary effects caused by Mediator structural alterations.

    • Solution Approaches:

      • Time-course experiments following ROX3 depletion

      • Separation-of-function mutations targeting specific aspects of ROX3 activity

      • Targeted rescue experiments with individual domains or artificial tethering

  • Purification Complexities

    • Challenge: Maintaining intact Mediator complexes during purification, as demonstrated by the differential effects of mild versus stringent conditions .

    • Solution Approaches:

      • Optimized gentle purification protocols

      • Cross-linking strategies to stabilize complexes

      • Rapid purification to minimize complex degradation

  • Functional Redundancy

    • Challenge: Potential compensatory mechanisms in vivo that mask ROX3's full range of functions.

    • Solution Approaches:

      • Combinatorial deletion studies

      • Synthetic genetic array analysis

      • In vitro reconstitution with defined components

How conserved is ROX3 function across different fungal species?

While the search results don't directly address ROX3 conservation, methodological approaches to studying evolutionary conservation include:

  • Sequence Analysis

    • Identification of ROX3 orthologs across fungal species

    • Determination of conserved domains and residues

    • Construction of phylogenetic trees to track evolutionary relationships

  • Functional Conservation Testing

    • Cross-species complementation experiments (can ROX3 from one species rescue deletion phenotypes in another?)

    • Analysis of protein-protein interaction conservation

    • Comparative structural studies of Mediator complexes

Based on research on other Mediator components, we would expect the architectural role of ROX3 to be highly conserved, while specific regulatory functions might show greater species-specific adaptation.

How does ROX3 function compare to other Mediator subunits?

The unique architectural role of ROX3 distinguishes it from many other Mediator subunits:

Mediator Component TypePrimary FunctionExample SubunitsROX3 Comparison
DNA-binding interfacesDirect interaction with regulatory elementsMed15, Med2ROX3 lacks direct DNA binding
Activator interfacesInteraction with transcription factorsMed15, Med16ROX3 primarily structural rather than directly regulatory
Architectural componentsMaintain Mediator structureROX3/Med19ROX3 exemplifies this category
Enzymatic componentsCatalytic activitiesCdk8 (kinase)ROX3 has no known enzymatic activity

ROX3's distinctive position as an intermodule connector enables it to influence transcriptional regulation through structural means rather than direct regulatory interactions. This makes it particularly valuable for understanding how Mediator architecture relates to function.

What experimental systems best recapitulate ROX3 function for in vitro studies?

Designing appropriate experimental systems for ROX3 functional studies presents several considerations:

  • Recombinant Protein Expression

    • Challenge: Obtaining properly folded, functional recombinant ROX3

    • Methodological solutions:

      • Expression in eukaryotic systems rather than bacterial systems

      • Co-expression with interacting Mediator subunits

      • Inclusion of chaperones to assist folding

  • Functional Reconstitution

    • For meaningful functional studies, ROX3 should be studied in the context of at least partial Mediator complexes

    • Stepwise reconstitution approaches can reveal which interactions are necessary and sufficient for ROX3 function

  • Activity Assays

    • In vitro transcription systems with purified components

    • Mediator assembly assays to monitor intermodule interactions

    • CTD phosphorylation assays reflecting the role of ROX3 in facilitating TFIIH activity

The most successful approaches combine multiple methods, correlating structural observations with functional outputs to build comprehensive models of ROX3 action.

How can chromatin context influence ROX3-dependent transcriptional regulation?

While the search results don't directly address chromatin interactions with ROX3, research approaches would include:

  • Chromatin Immunoprecipitation Studies

    • Comparing ROX3 occupancy at genes with different chromatin states

    • Analyzing ROX3-dependent recruitment of chromatin modifiers

  • Genetic Interaction Analysis

    • Testing for interactions between ROX3 and chromatin modifiers such as RPD3

    • Analyzing transcriptional effects in strains with combined deletions

  • In Vitro Transcription on Chromatin Templates

    • Assessing how nucleosomal templates affect ROX3-dependent transcription

    • Determining if ROX3 influences Mediator's ability to function with chromatinized templates

This research direction would connect ROX3's structural role to the broader context of chromatin-regulated transcription, potentially revealing additional functional aspects.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.